Tuberculosis News and Research

Latest Tuberculosis News and Research

Global health innovation system fails to deliver affordable treatments to patients, says report

NHS patients are being let down by a global health innovation system which fails to deliver the treatments they need at prices that government can afford, according to a new report led by Professor Mariana Mazzucato, Director of the UCL Institute for Innovation and Public Purpose, in collaboration with STOPAIDS, Global Justice Now and Just Treatment.

15 Oct 2018

Healthcare systems fail to deliver at affordable prices finds report

According to a new report from Professor Mariana Mazzucato, Director of the UCL Institute for Innovation and Public Purpose (IIPP), in collaboration with STOPAIDS, Global Justice Now and Just Treatment, the NHS patients are not getting treatments at affordable process and this is a failure on part of the global health innovation system.

15 Oct 2018

Scripps Research scientists discover role of immune system double agent

Scientists at Scripps Research have discovered the role of an immune system double agent. This molecule, called USP18, can help curtail immune responses, but it can also open the door to bacterial infections, such as harmful listeria and staph infections.

5 Oct 2018

UConn chemists develop new antibiotic that can find and kill tuberculosis bacteria

Tuberculosis is a sneaky disease. The bacteria hide from antibiotics inside the very immune cells that are supposed to kill them, making treatment long and difficult. But in the November issue of ACS Infectious Diseases, UConn chemists report a new antibiotic that can find and kill tuberculosis bacteria where they hide.

4 Oct 2018

New ReFRAME drug repurposing collection offers hope for treating major diseases

Each year, millions of people worldwide suffer from potentially fatal infectious diseases that often leave survivors facing a lifetime of related health problems. But what if drugs against such diseases already existed but nobody knew it?

4 Oct 2018

Decibel obtains exclusive license to commercialize ORC-13661 for preventing hearing, balance disorders

Decibel Therapeutics and Oricula Therapeutics today announced that Decibel has obtained an exclusive, worldwide license to the development and commercialization of ORC-13661, an oral medication developed by Oricula Therapeutics for the prevention of hearing loss and balance disorders that can occur following treatment of severe infections with aminoglycoside antibiotics.

27 Sep 2018

NIAID releases strategic plan to expand knowledge of TB by using modern tools

Tuberculosis (TB) is the leading infectious cause of death worldwide, killing roughly 1.6 million people in 2017. In the past 200 years, TB claimed the lives of more than one billion people--more deaths than from malaria, influenza, smallpox, HIV/AIDS, cholera and plague combined.

27 Sep 2018

Diabetes patients with poor blood sugar control face highest risk of serious infections

A new study has shown that diabetes patients with the poorest control of their blood sugars face the highest risks of hospitalization and death due to infections.

26 Sep 2018

New TB vaccine effective in half of the population in phase II trials

GlaxoSmithKline has come up with an experimental vaccine against tuberculosis (TB) that has shown effective prevention of the infection in half of the population it has been administered to. This could be a breakthrough in preventing the killer disease say researchers since most of the recent vaccines developed against the disease have failed to show efficacy.

26 Sep 2018

‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms

Alcohol is a leading contributor to death and disability worldwide, but governments haven’t responded to the issue with the attention, resources and action this urgent issue requires, says “Trouble Brewing,” a new report from global health and development organizations, Vital Strategies, the NCD Alliance, IOGT International and the Global Alcohol Policy Alliance.

25 Sep 2018

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.

21 Sep 2018

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

A naturally occurring antibiotic called kanglemycin A is effective against Mycobacterium tuberculosis, the bacteria that cause tuberculosis, even in drug-resistant strains, according to an international team of researchers who used chemistry, molecular biology, microbiology, and X-ray crystallography to show how the compound maintains its activity.

21 Sep 2018

LSTM partners with TB Alliance to develop novel TB drug regimens

LSTM and TB Alliance are collaborating to investigate novel combination drug therapies that could help the fight against multidrug-resistant tuberculosis (MDR-TB), following an award of £1 million from the Medical Research Council.

19 Sep 2018

QIAGEN and DiaSorin launch automated, CE-marked workflow for high-throughput TB screening

QIAGEN N.V. and DiaSorin today announced the introduction of an automated, CE-marked workflow for QIAGEN’s QuantiFERON-TB Gold Plus Blood Collection Tubes (QFT-Plus BCT) and a novel DiaSorin LIAISON Test on widely used immunodiagnostic instruments from DiaSorin.

17 Sep 2018

Inhaled steroid use linked to greater risk of NTM lung infections

Patients using inhaled steroids to control asthma and other breathing problems may be at greater risk for developing nontuberculous mycobacteria lung infections, according to new research published online in the Annals of the American Thoracic Society.

17 Sep 2018

Scientists develop first non-antibiotic drug to treat tuberculosis in animals

Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals.

11 Sep 2018

Effective vaccines for world's most prevalent infectious diseases are missing from pipeline

Many of the vaccines critically needed to fight some of the world's most prevalent infectious diseases are not likely to be developed, a new analysis of current candidates in the research and development pipeline has found.

5 Sep 2018

Study provides insights into how harmful white blood cells form during tuberculosis

Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.

31 Aug 2018

Around 8.4 million deaths occur each year from poor quality of care in low- and middle-income countries

Recent gains against the burden of illness, injury, and disability and commitment to universal health coverage are insufficient to close the enormous gaps that remain between what is achievable in human health and where global health stands today, says a new report from the National Academies of Sciences, Engineering, and Medicine.

29 Aug 2018

New Cochrane Review assesses accuracy of Xpert in diagnosing extrapulmonary TB

In one-fifth of people with active tuberculosis, the site of disease is outside the lungs. Some forms of extrapulmonary TB, such as TB meningitis, are extremely dangerous, where a rapid diagnosis can make all the difference to a patient.

28 Aug 2018

Tuberculosis News and Research

Latest Tuberculosis News and Research

Global health innovation system fails to deliver affordable treatments to patients, says report

Healthcare systems fail to deliver at affordable prices finds report

Scripps Research scientists discover role of immune system double agent

UConn chemists develop new antibiotic that can find and kill tuberculosis bacteria

New ReFRAME drug repurposing collection offers hope for treating major diseases

Decibel obtains exclusive license to commercialize ORC-13661 for preventing hearing, balance disorders

NIAID releases strategic plan to expand knowledge of TB by using modern tools

Diabetes patients with poor blood sugar control face highest risk of serious infections

New TB vaccine effective in half of the population in phase II trials

‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

LSTM partners with TB Alliance to develop novel TB drug regimens

QIAGEN and DiaSorin launch automated, CE-marked workflow for high-throughput TB screening

Inhaled steroid use linked to greater risk of NTM lung infections

Scientists develop first non-antibiotic drug to treat tuberculosis in animals

Effective vaccines for world's most prevalent infectious diseases are missing from pipeline

Study provides insights into how harmful white blood cells form during tuberculosis

Around 8.4 million deaths occur each year from poor quality of care in low- and middle-income countries

New Cochrane Review assesses accuracy of Xpert in diagnosing extrapulmonary TB

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Tuberculosis News and Research

Latest Tuberculosis News and Research

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in